Nasdaq Files 19b-4 For 21Shares Sui ETF With US SEC

Highlights

Nasdaq has filed the 19b-4 to list and trade shares of the 21Shares Sui ETF.
This officially begins the review process, during which the SEC would have to approve or deny.
The SEC has delayed other crypto ETFs so far.

21Shares has taken another step towards the launch of its Sui ETF. This time, the Nasdaq Stock Exchange has filed Form 19b-4 with the U.S. Securities and Exchange Commission (SEC) on behalf of the asset manager to list and trade shares of this fund.

Nasdaq Files 19b-4 To List & Trade 21Shares Sui ETF

A SEC filing has shown that Nasdaq has filed the Form 19b-4 to list and trade shares of 21Shares Sui ETF on its stock exchange. This officially initiates the review process, during which the Commission will approve or deny the application.

As CoinGape earlier reported, 21Shares has shown its intention to offer this ETF when the asset manager filed the S-1 with the SEC earlier this month. This fund will provide institutional investors with exposure to SUI, which is the native token of the Sui network.

The Sui price is in the green amid Nasdaq’s filing, currently trading at around $3.64. The altcoin has surged almost 2% in the last 24 hours. However, it is down 3% in the last seven days.

Nasdaq’s 19b-4 filing comes following the Cetus $223 million hack, which shook the Sui ecosystem last week. The team has so far frozen $160 million of the stolen funds and has launched a $6 million reward to recover the remaining amount.

The Sui network released a report yesterday confirming that the hack was due to a bug in Cetus’ math library, rather than a vulnerability in the network or its Move programming language. The network also launched a $10 million fund to boost the ecosystem’s security.

It is worth mentioning that 21Shares and Canary Capital are the only two asset managers that have filed to offer a Sui ETF. CBOE had filed the 19b-4 for Canary Capital’s ETF last month.

Based on predictions by Bloomberg analysts Eric Balchunas and James Seyffart, the SEC is unlikely to approve these funds anytime soon. Instead, they predict that approval for the crypto ETFs will come in the early part of the fourth quarter of this year. The SEC recently delayed the CoinShares XRP ETF.

TAGS
Sui (SUI)

Recommended
Price Analysis

Best Crypto Presales To Invest In September 2025 – Top Upcoming Presale Tokens

Best Crypto AI Trading Bots In 2025

Top Meme Coins To Buy In September 2025

Boluwatife Adeyemi

Boluwatife Adeyemi is a well-experienced crypto news writer and editor who has covered topics that cut across several niches. His speed and alacrity in covering breaking updates are second to none. He has a knack for simplifying the most technical concepts and making them easy for crypto newbies to understand. Boluwatife is also a lawyer, who holds a law degree from the University of Ibadan. He also holds a certification in Digital Marketing. Away from writing, he is an avid basketball lover, a traveler, and a part-time degen.

Why trust CoinGape: CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights to our readers. Our journalists and analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.

Investment disclaimer: The content reflects the author’s personal views and current market conditions. Please conduct your own research before investing in cryptocurrencies, as neither the author nor the publication is responsible for any financial losses.

Ad Disclosure: This site may feature sponsored content and affiliate links. All advertisements are clearly labeled, and ad partners have no influence over our editorial content.